Truist Financial’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Sell
7,256
-23,542
-76% -$3.57M ﹤0.01% 1543
2025
Q1
$4.64M Buy
30,798
+856
+3% +$129K 0.01% 863
2024
Q4
$5.53M Sell
29,942
-4,250
-12% -$785K 0.01% 781
2024
Q3
$6.73M Sell
34,192
-3,032
-8% -$597K 0.01% 714
2024
Q2
$7.69M Sell
37,224
-2,761
-7% -$570K 0.01% 689
2024
Q1
$10.8M Sell
39,985
-970
-2% -$263K 0.02% 598
2023
Q4
$9.68M Sell
40,955
-1,106
-3% -$261K 0.02% 625
2023
Q3
$8.24M Buy
42,061
+1,255
+3% +$246K 0.01% 644
2023
Q2
$8.58M Sell
40,806
-527
-1% -$111K 0.01% 638
2023
Q1
$8.34M Buy
41,333
+1,038
+3% +$209K 0.01% 638
2022
Q4
$8.78M Buy
40,295
+570
+1% +$124K 0.02% 615
2022
Q3
$7.82M Buy
39,725
+2,281
+6% +$449K 0.02% 641
2022
Q2
$8.01M Sell
37,444
-2,096
-5% -$448K 0.01% 650
2022
Q1
$11.2M Buy
39,540
+5,085
+15% +$1.44M 0.02% 603
2021
Q4
$13M Buy
34,455
+1,144
+3% +$431K 0.02% 553
2021
Q3
$13.7M Buy
33,311
+1,384
+4% +$571K 0.02% 525
2021
Q2
$11.8M Buy
31,927
+2,117
+7% +$783K 0.02% 576
2021
Q1
$8.64M Buy
29,810
+1,555
+6% +$451K 0.02% 643
2020
Q4
$7.06M Sell
28,255
-161
-0.6% -$40.2K 0.01% 708
2020
Q3
$6.44M Sell
28,416
-4,132
-13% -$936K 0.01% 677
2020
Q2
$5.68M Sell
32,548
-5,216
-14% -$909K 0.01% 695
2020
Q1
$4.77M Sell
37,764
-387
-1% -$48.9K 0.01% 688
2019
Q4
$5.83M Buy
38,151
+13,448
+54% +$2.05M 0.01% 703
2019
Q3
$3.27M Sell
24,703
-574
-2% -$76K 0.06% 282
2019
Q2
$3.59M Sell
25,277
-1,193
-5% -$169K 0.06% 263
2019
Q1
$3.85M Sell
26,470
-145
-0.5% -$21.1K 0.07% 256
2018
Q4
$3.01M Buy
26,615
+444
+2% +$50.2K 0.06% 274
2018
Q3
$3.52M Sell
26,171
-956
-4% -$129K 0.06% 280
2018
Q2
$3.05M Sell
27,127
-2,004
-7% -$225K 0.06% 302
2018
Q1
$3.11M Sell
29,131
-1,965
-6% -$210K 0.06% 294
2017
Q4
$3.4M Sell
31,096
-642
-2% -$70.3K 0.06% 287
2017
Q3
$3.43M Buy
+31,738
New +$3.43M 0.07% 282